Portfolio Design Labs’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$770K Buy
12,340
+46
+0.4% +$2.91K 0.12% 135
2026
Q2
$708K Buy
12,294
+52
+0.4% +$2.99K 0.12% 140
2026
Q1
$742K Buy
12,242
+4,027
+49% +$235K 0.13% 151
2025
Q4
$443K Buy
8,215
+1,291
+19% +$62.1K 0.07% 159
2025
Q3
$312K Sell
6,924
-52,276
-88% -$2.44M 0.05% 168
2025
Q2
$2.74M Buy
59,200
+8,779
+17% +$431K 0.54% 56
2025
Q1
$3.08M Sell
50,421
-215
-0.4% -$12.5K 0.63% 54
2024
Q4
$2.86M Buy
50,636
+12,930
+34% +$722K 0.59% 49
2024
Q3
$1.95M Buy
+37,706
New +$1.77M 0.54% 59

Other funds holding BMY

Portfolio Design Labs's BMY Position: Q3 2026 in Review

Portfolio Design Labs increased its Bristol-Myers Squibb (BMY) stake by 0.37% in Q3 2026, buying an estimated $2.91K and bringing the position to 12,340 shares worth $770K. The position accounts for 0.12% of the portfolio, ranked #135.

Portfolio Design Labs first reported a position in BMY in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.08M in Q1 2025. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Portfolio Design Labs held 12,340 shares of Bristol-Myers Squibb worth $770K as of Q3 2026.
  • Portfolio Design Labs bought 46 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.91K.
  • Bristol-Myers Squibb made up 0.12% of Portfolio Design Labs's portfolio in Q3 2026, its #135 holding.
  • Portfolio Design Labs first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 9 quarters since.
  • Portfolio Design Labs's Bristol-Myers Squibb position peaked at $3.08M in Q1 2025.
  • 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Portfolio Design Labs's 13F filing for Q3 2026, filed 4 Nov 2026.